A Study of TEPEZZA® Treatment in Participants With Thyroid Eye Disease

Summary

The main goal of this study is to learn how teprotumumab will be processed in the body (Pharmacokinetics) subcutaneously and whether it is safe and tolerable after administration into adult patients with thyroid eye disease.

Timeline

Start

2022-07-14

Primary completion

2023-02-28

Completion

2023-09-12

Drugs

Indications